205 related articles for article (PubMed ID: 4843162)
1. Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma.
Zaharko DS; Dedrick RL; Peale AL; Drake JC; Lutz RJ
J Pharmacol Exp Ther; 1974 Jun; 189(3):585-92. PubMed ID: 4843162
[No Abstract] [Full Text] [Related]
2. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
Sirotnak FM; Donsbach RC
Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
[No Abstract] [Full Text] [Related]
3. Relative biochemical aspects of low and high doses of methotrexate in mice.
Zaharko DS; Fung WP; Yang KH
Cancer Res; 1977 Jun; 37(6):1602-7. PubMed ID: 870175
[TBL] [Abstract][Full Text] [Related]
4. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
Shapiro WR
Cancer Res; 1972 Oct; 32(10):2178-85. PubMed ID: 5080762
[No Abstract] [Full Text] [Related]
5. [Study of DNA synthesis in short-term cultures of mammalian cells in the evaluation of the reaction of tumor and normal tissues to irradiation and hyperthermia].
Synzynys BI; Kolesnikova AI; Konopliannikova AG
Radiobiologiia; 1985; 25(2):179-84. PubMed ID: 4001315
[TBL] [Abstract][Full Text] [Related]
6. Duration of inhibition of synthesis of DNA in tumors and host tissues after single doses of nitrosoureas.
Wheeler GP; Alexander JA
Cancer Res; 1974 Aug; 34(8):1957-64. PubMed ID: 4842249
[No Abstract] [Full Text] [Related]
7. High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.
Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
Cancer Treat Rep; 1977 Jul; 61(4):565-74. PubMed ID: 301778
[No Abstract] [Full Text] [Related]
8. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
Chabner BA; Young RC
J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
[TBL] [Abstract][Full Text] [Related]
9. The effect of inhibition of cytidine deaminase by tetrahydrouridine on the utilization of deoxycytidine and 5-bromodeoxycytidine for deoxyribonucleic acid synthesis.
Cooper GM; Greer S
Mol Pharmacol; 1973 Nov; 9(6):698-703. PubMed ID: 4762631
[No Abstract] [Full Text] [Related]
10. The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells.
Goldman ID; Fyfe MJ
Mol Pharmacol; 1974 Mar; 10(2):275-82. PubMed ID: 4859543
[No Abstract] [Full Text] [Related]
11. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
Mayo JG
Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
[No Abstract] [Full Text] [Related]
12. L-asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y.
Capizzi RL; Summers WP; Bertino JR
Ann N Y Acad Sci; 1971 Nov; 186():302-11. PubMed ID: 5289422
[No Abstract] [Full Text] [Related]
13. Preferential inhibition of DNA synthesis in mouse hemopoietic cells by halothane.
Evenwel RF; Keizer HJ; van Putten LM
Cancer Res; 1976 Sep; 36(9 pt.1):3156-9. PubMed ID: 975081
[TBL] [Abstract][Full Text] [Related]
14. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
Klubes P; Connelly K; Cerna I; Mandel HG
Cancer Res; 1978 Aug; 38(8):2325-31. PubMed ID: 667828
[No Abstract] [Full Text] [Related]
15. Growth rate and cell kill.
Hryniuk WM; Bertino JR
Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
[No Abstract] [Full Text] [Related]
16. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
Chabner BA; Chello PL; Bertino JR
Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
[No Abstract] [Full Text] [Related]
17. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
Kawai M; Hillcoat BL
Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
[No Abstract] [Full Text] [Related]
18. Pharmacokinetic basis for differences in methotrexate sensitivity of normal proliferative tissues in the mouse.
Sirotnak FM; Moccio DM
Cancer Res; 1980 Apr; 40(4):1230-4. PubMed ID: 7357552
[TBL] [Abstract][Full Text] [Related]
19. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
Chu BC; Whiteley JM
J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
[TBL] [Abstract][Full Text] [Related]
20. Uptake and distribution of 3 H-methotrexate by the murine ependymoblastoma.
Levin VA; Clancy TP; Ausman JI; Rall DP
J Natl Cancer Inst; 1972 Apr; 48(4):875-83. PubMed ID: 4537157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
